• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Gut Microbiome

Seed Health Acquires Auggi’s Stool Recognition AI Tech & Algorithms

by Jasmine Pennic 02/12/2021 Leave a Comment

Seed Health Announces Acquisition of Digital Health Company Augg

What You Should Know: - Seed Healthv, a microbial sciences company, announced the acquisition of Auggi, a digital health company with a suite of artificial intelligence and machine learning technologies to track and analyze digestive health. - As part of the acquisition, Seed Health will acquire Auggi's technology assets, including its AI algorithm for real-time Bristol stool typing, the world's largest stool image database, and a mobile monitoring application for clinical research. -
Read More

Sun Genomics and DexaFit Partner to Integrate Gut Health Testing

by Fred Pennic 12/17/2019 Leave a Comment

Sun Genomics and DexaFit Partner to Integrate Gut Health Testing

- Sun Genomics partners with DexaFit to integrate gut health testing to offer microbiome analysis and insights at 27 health and wellness clinics nationwide.  - With the addition of Sun Genomics Floré testing, DexaFit is now incorporating microbiome analysis into its approach to give its clients a thorough understanding of their gut DNA or microbiome to further measure and improve their overall health and performance.  Sun Genomics today announced that it is partnering with DexaFit, the
Read More

Cleveland Clinic Awarded $12M to Study Link Between Gut Microbes & Heart Disease

by Jasmine Pennic 11/22/2019 Leave a Comment

Cleveland Clinic Awarded $12M to Study Gut Microbes and Heart Disease

- Stanley Hazen, M.D., Ph.D., director of Cleveland Clinic's Center for Microbiome & Human Health and his team has been awarded a $12M NIH grant to study the link between gut microbes, heart disease. - The new research program will consist of three specialized projects and four supporting cores focused on the gut microbiome. TheNational Institutes of Health (NIH) has awarded more than $12 million to Cleveland Clinic researchers to study the critical link between gut microbial pathways and
Read More

Sun Genomics Delivers Personalized Probiotics In Only 6 Weeks to Address Gut Health Issues

by Fred Pennic 10/25/2019 Leave a Comment

Sun Genomics Delivers Personalized Probiotics In Only 6 Weeks to Address Gut Health Issues

- Sun Genomics launches personalized probiotic solution to identify and address individual gut health issues to improve the health of millions of Americans. - Solution delivers precise probiotic formula required for each person to address their own unique gut health issues in just six weeks. - Sun Genomics Floré includes a kit to collect a micro-stool sample, a full microbiome analysis report, and a 90-day supply of precision probiotics.Sun Genomics today launched the first customized
Read More

BiomeSense Nabs $2M to Expand Daily Gut Microbiome Tracking Platform

by Fred Pennic 10/04/2019 Leave a Comment

BiomeSense Nabs $2M to Expand Biosensor & Analytics Platform for Daily Gut Microbiome Tracking

- BiomeSense raises $2M in seed funding to expand its biosensor and analytics platform for daily gut microbiome tracking. - The company is working on completing its prototype biosensor and data modeling platform in preparation for the first clinical trials, scheduled for 2020.- The trials will investigate cancer progression, immunotherapy response, surgical recovery and athletic performance.BiomeSense, a Chicago, IL-based microbiome startup developing a novel biosensor and analytics platform for
Read More

Mayo Clinic to Leverage Viome’s Microbiome Analysis Platform in Study to Help Understand Sleep and Obesity

by Jasmine Pennic 07/29/2019 Leave a Comment

Mayo Clinic to Leverage Viome’s Microbiome Analysis Platform in Study

Mayo Clinic is collaborating on a study with Viome, a company transforming health through personalized nutrition based on individual biology to better understand the role of nutrition in disease and to explore the potential of Viome's AI-driven personalized diets in helping manage sleep disorders such as sleep apnea and obesity. Understanding Microbiome A person’s microbiome is the entire collection of microbes living in and on the body. The microbiome forms a living layer over your skin
Read More

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |